Maple Grove, Minnesota, July 29, 2026 – VDyne Inc. (“VDyne”), a privately held medical device company developing an innovative transcatheter tricuspid valve replacement (TTVR) system, today announced that the first patient has been enrolled and treated in the TRIVITA US IDE pivotal study of the TriNovaTM system. The randomized controlled […]
Tag: VDyne
VDyne Appoints Mike Buck as Chairman and CEO to Lead Next Phase of its TTVR Program
MAPLE GROVE, Minn.–(BUSINESS WIRE)–VDyne Inc. (“VDyne”), a privately held medical device company developing a transcatheter tricuspid valve replacement (TTVR) system to treat tricuspid regurgitation, today announced the appointment of Mike Buck as Chairman and Chief Executive Officer. Mr. Buck brings more than 30 years of leadership experience in cardiovascular medical […]



